Tesamorelin
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It stimulates the pituitary gland to release natural growth hormone (GH), which in turn elevates IGF-1 levels. It is FDA-approved for the treatment of HIV-associated lipodystrophy (excess abdominal fat in HIV patients).
$ 80.00 USD
Research Overview
Key Benefits
- Reduction of Visceral Fat
- Clinically proven to significantly reduce deep abdominal fat (VAT) in people with HIV-associated lipodystrophy.
- Improves body composition without reducing subcutaneous fat.
- Muscle & Metabolic Support
- Increases natural GH and IGF-1 production, supporting lean muscle maintenance.
- May improve lipid metabolism and reduce triglycerides.
- Skin, Tissue & Anti-Aging Effects
- Growth hormone stimulation supports collagen synthesis, skin elasticity, and tissue repair.
- Potential benefits for age-related body composition changes.
- Cognitive & Neuroprotective Potential
- Early research suggests Tesamorelin may benefit cognitive function and brain health in aging populations.
Why It’s Unique
- Selectively stimulates the body’s own growth hormone production, rather than supplying GH directly.
- Daily subcutaneous injection with a well-established safety profile.
- One of the few peptides with FDA approval for a specific medical indication.
Accepting
